Who We Are >
NEWS
Foundation Care now provides Zenpep™ (Pancrelipase) Delayed-Release Capsules!
November 30, 2009 - New to the market, Zenpep ™ (Pancrelipase) Delayed-Release Capsules 7% is now commercially available. Manufactured by Eurand®, Zenpep is a pancreatic enzyme product (PEP) indicated for the treatment of exocrine pancreatic insufficiency (EPI) due to cystic fibrosis (CF) or other conditions.
Foundation Care partnered with Eurand Pharmaceuticals to provide patients with direct access to the new digestive enzyme, Zenpep™ (Pancrelipase) Delayed-Release Capsules.
An advantage to getting a prescription of Zenpep is the new Z-Points Program. With each fill of a one month supply, eligible patients will earn points that can be applied towards products and equipment you use every day. Patients may enroll in the program by going to www.ZENPEP.com. Items patients can receive FREE with points are:
- The Trio™ Electronic Nebulizer (formerly eFlow® SCF)
- An additional handset for those who currently have a Trio
- Vitamins
- Nutritional products
- Gift cards
Cystic Fibrosis is an inherited chronic disease that affects the lungs and digestive system of about 30,000 children and adults in the United States (70,000 worldwide).
About Foundation Care
As a full service pharmacy, Foundation Care continues to provide the most up-to-date medications while working to make our patients treatment easier and more affordable. Located in the Saint Louis, MO area, Foundation Care serves patients locally and nationwide. For additional information, visit www.FoundCare.com or call Foundation Care at (314) 291-1122 or toll‐free at (877) 291-1122.